Research Article
1 Pediatric Hematology-Oncology Fellow, Department of Pediatrics, Division of Pediatric Hematology-Oncology, Montreal Children’s Hospital, McGill University, Montreal, Québec, Canada
2 Pediatric Intensivist, Department of Pediatrics, Division of Pediatric Intensive Care, CHU Sainte-Justine, Université de Montréal, Montreal, Québec, Canada
3 Neonatologist, Department of Pediatrics, Division of Neonatology, CHU Sainte-Justine, Université de Montréal, Montreal, Québec, Canada
4 Emergency Physician, Department of Emergency Medicine, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montreal, Québec, Canada
Address correspondence to:
Alexandra Zabeida
313 rue Caisse, Verdun, QC H4G 3M3,
Canada
Message to Corresponding Author
Article ID: 100072Z02AZ2022
Aims: Platelet transfusions are common in the neonatal intensive care unit (NICU), yet practices vary substantially. This study aims to determine platelet transfusion incidence, determinants, and justifications in neonatology.
Methods: Single-center prospective cohort study, including all patients consecutively admitted to the CHU Sainte-Justine Hospital NICU over a 5-month period in 2013. Data were collected by chart review and transfusion justifications were assessed using a questionnaire.
Results: A total of 401 participants were included. Mean birth weight (BW) was 2.34±1.01 kg and gestational age (GA) was 34.4±4.5 weeks. Thirty-seven neonates (9.2%) received at least one platelet transfusion. Platelet-transfused neonates were mostly extremely preterm (40.5%) or term (24.3%). The median pre-platelet transfusion count was 57 × 109/L (9–285 × 109/L). Compared to non-transfused patients, those who received at least one platelet transfusion had a significantly lower BW and GA, higher CRIB-II and SNAPPE-II scores (all p <0.001) and were more frequently admitted for respiratory disease (p <0.001), hypoxic-ischemic encephalopathy (p=0.009), and hemolytic disease of the newborn (p <0.001). Gestational age <28 weeks (p<0.001), mechanical ventilation requirements (p=0.008), and platelet nadir ≤150 × 109/L (p<0.001) upon admission were independently associated with a higher risk of platelet transfusion in this cohort. Most frequent justifications for ordering a first platelet transfusion were low platelet counts (86.5%), underlying disease (78.4%) and illness severity (37.8%).
Conclusion: Pre-transfusion platelet counts in neonates varied widely and were higher than the thresholds proposed in the literature. Several factors other than platelet count predicted risk of platelet transfusion in this cohort.
Keywords: Neonatology, Platelet, Thrombocytopenia, Transfusion
We would like to thank Miguel Chagnon for his contribution to the statistical analysis, as well as the Fonds Fonds de la Recherche du Québec—Santé for funding this project.
Author ContributionsAlexandra Zabeida - Acquisition of data, Analysis of data, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Jacques Lacroix - Conception of the work, Design of the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Anie Lapointe - Conception of the work, Design of the work, Acquisition of data, Analysis of data, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Christian Lachance - Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Alexis Cournoyer - Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Andréanne Villeneuve - Conception of the work, Design of the work, Acquisition of data, Analysis of data, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Guarantor of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2022 Alexandra Zabeida et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.